‘Vroegefaseproject’ loan granted to commercialize PACT, the platelet function test image

UTRECHT, THE NETHERLANDS, JULY 16th 2018 – The NWO domain Applied and Technical Sciences (TTW, formerly known as the Technology Foundation STW) has granted a loan for the Take-off phase 2 project ‘PACT, a new diagnostic tool to assess platelet function in the bleeding patient’.  The grant in the amount of € 150.000 will be used for the commercial application of the PACT to improve platelet diagnostics in patients at risk of bleeding by implementing PACT in the diagnostic clinical setting and to obtain CE marking for entry onto the (inter)national market. Entrepreneurship The Take-off phase 2 program is part of a science-wide funding instrument of ZonMw and NWO, which is financed by the Dutch Ministry of Economic Affairs and Climate ...

Continue Reading

U-PACT receives MIT R&D collaborative project grant from the Economic Board Utrecht image

UTRECHT, THE NETHERLANDS, JANUARY 12th 2017 – U-PACT B.V., the molecular diagnostics company that develops technology to provide comprehensive tools for accurate assessment of bleeding risk, has received the MIT R&D collaborative project grant from the Economic Board Utrecht. The application entitled ‘PACT, a platelet activation test that predicts bleeding risk’ was rated as more innovative compared to other applications with respect to its product development, and judged much better than average regarding its economic value. In collaboration with U-Protein Express B.V., U-PACT B.V. will use this grant to develop and validate novel reagents for its platelet function test PACT. For more information on the PACT, please contact Dr. Suzanne Korporaal, C.O.O. at J.A.Korporaal@U-PACT.com. For more information on U-PACT B.V., please contact ...

Continue Reading

Take-off Phase 1 – Feasibility project grant to prepare for commercialization of PACT, the platelet function test image

UTRECHT, THE NETHERLANDS, DECEMBER 21th 2016 – The NWO domain Applied and Technical Sciences (TTW, formerly known as the Technology Foundation STW) has provided funding for the Take-off phase 1 – feasibility project ‘PACT, a new tool to assess platelet function in the bleeding patient’. The grant in the amount of € 40,000 will be used to study feasibility of commercial application of the PACT to improve platelet diagnostics in patients at risk of bleeding. The aim is to gain insight into what is needed for implementation in the diagnostic clinical setting and to obtain CE marking for entry onto the (inter)national market. For more information on the PACT, please contact Dr. Suzanne Korporaal, C.O.O. at J.A.Korporaal@U-PACT.com. For more information on U-PACT ...

Continue Reading

Platelet function test PACT wins incentive award at public meets private event of the University Medical Center Utrecht image

UTRECHT, THE NETHERLANDS, JUNE 3 2016 – During the public meets private event Circulation of Knowledge organized by the Center of Circulatory Health of the University Medical Center Utrecht, PACT was awarded with an encouragement price because of its clear added value for future diagnostics and treatment of patients at risk of bleeding. Foto: UMC Utrecht The jury of Circulation of Knowledge was impressed with the valorisation and validation opportunities of the PACT and envisions an important future for the test in clinical diagnostics. The jury awarded the invention with an incentive of 50,000 euros, provided that it is matched with an equivalent investment from the private industry. --> For more information on validation of the PACT, please contact Dr. Suzanne ...

Continue Reading

U-PACT closes license and collaboration agreement with University Medical Center Utrecht image

UTRECHT, THE NETHERLANDS, MARCH 29 2016 - U-PACT B.V., the platelet diagnostics company based in the Netherlands, announces that it has closed its biologicals license agreement with University Medical Center Utrecht (UMC Utrecht) for the exclusive rights on the proprietary biological reagents and methodology of the PACT assay. U-PACT will use the biological reagents and methodology to develop and validate the PACT assay for commercial sale. U-PACT is a specialized platelet diagnostics company that develops, validates, manufactures and sells platelet diagnostic tools. For more information on U-PACT, please contact Dr. Martin Hessing ...

Continue Reading

This is a unique website which will require a more modern browser to work!

Please upgrade today!